Status:

ACTIVE_NOT_RECRUITING

Preoperative Optimization of Diabetic Patients

Lead Sponsor:

University of Alberta

Conditions:

Diabetes

Surgery Related Complications Rate

Eligibility:

All Genders

18+ years

Brief Summary

Diabetic patients, as part of preoperative evaluation, should have glycated hemoglobin (HbA1C) measured. HbA1C provides information on longterm glucose control. There is a suggestion in the literature...

Detailed Description

Purpose: The purpose of this study to retrospectively determine the incidence of diabetes in the surgical population and what proportion of diabetic patients have a valid HbA1C. Hypothesis: A valid (m...

Eligibility Criteria

Inclusion

  • Age 18 or greater
  • Having any surgical procedure at any hospital in Alberta

Exclusion

    Key Trial Info

    Start Date :

    January 22 2025

    Trial Type :

    OBSERVATIONAL

    Allocation :

    ACTUAL

    End Date :

    March 1 2026

    Estimated Enrollment :

    46000 Patients enrolled

    Trial Details

    Trial ID

    NCT06589466

    Start Date

    January 22 2025

    End Date

    March 1 2026

    Last Update

    April 17 2025

    Active Locations (1)

    Enter a location and click search to find clinical trials sorted by distance.

    Page 1 of 1 (1 locations)

    1

    University of Alberta

    Edmonton, Alberta, Canada, T6G2R3